Inflammatory bowel disease and thromboembolism. Is inflammation at the centre of the clot?
Thromboembolic events are well recognised in patients with inflammatory bowel disease (IBD). We present three cases which highlight the need for vigilance with respect to this complication. We also propose that consideration be given to re-evaluating disease activity in those patients who develop thromboembolic complications.
Acute Medical Assessment Unit, Mid Western Regional Hospital, Dooradoyle, Limerick. amof_2001@yahoo.co.uk
A M
AM
O'Flynn
M
M
Watts
D
D
Wall
C
C
Molefe
D
D
O'Keeffe
P
P
Finucane
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000150:complications; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D007866:Leg / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D017131:Thrombectomy; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D000078222:Tinzaparin; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D000078222:Tinzaparin